<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03921372</url>
  </required_header>
  <id_info>
    <org_study_id>IsometricProtocol2</org_study_id>
    <nct_id>NCT03921372</nct_id>
  </id_info>
  <brief_title>Isometric Exercise in NTG</brief_title>
  <official_title>Optic Nerve Head Blood Flow Regulation During Isometric Exercise in Patients With Normal Tension Glaucoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augenabteilung Allgemeines Krankenhaus Linz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Augenabteilung Allgemeines Krankenhaus Linz</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Glaucoma is the second leading cause of blindness worldwide. Literature shows increasing
      evidence that dysfunction of ocular microcirculation in the optic nerve influences the
      progression of glaucoma. It has been shown that flicker light-induced vasodilatation of
      retinal veins is diminished in patients with glaucoma. Also previous studies indicate that
      the blood flow autoregulation is impaired in patients with glaucoma. Therefor the ocular
      perfusion pressure can not be maintained stable during changes of the systemic arterial blood
      pressure. Laser speckle flowgraphy (LSFG) represents a non-invasive method to quantify ocular
      perfusion also at the ONH. LSFG enables noninvasive quantification of microcirculation of the
      optic disc in Japanese glaucoma patients.

      Study Objectives:

      To assess the changes in LSFG parameters in patients with normal tension glaucoma, compared
      to healthy subjects during flicker light stimulation and isometric exercises.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 26, 2018</start_date>
  <completion_date type="Actual">February 25, 2019</completion_date>
  <primary_completion_date type="Actual">February 25, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in mean blur rate</measure>
    <time_frame>5 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Mean Blur Ratio</condition>
  <arm_group>
    <arm_group_label>Normal Tension Glaucoma (NTG)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with diagnosed NTG</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Control Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects with no sign of glaucoma, Age and sex matched</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Isometric exercise</intervention_name>
    <description>Squatting for 5 minutes</description>
    <arm_group_label>Healthy Control Subjects</arm_group_label>
    <arm_group_label>Normal Tension Glaucoma (NTG)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        1. Study population: patients with normal tension glaucoma

               -  Caucasian men and women aged over 50 years

               -  Subject is generally healthy with no current significant or a history of a
                  significant neurological, cardiovascular, pulmonary (including asthma), hepatic,
                  metabolic, rheumatic, autoimmune, hematological or renal disorder, as determined
                  by the investigator's clinical judgment through collection of medical history and
                  performance of a physical examination. A significant disorder is defined as a
                  disease or medical condition associated with impaired health status, requiring
                  regular or current medical treatment and/or follow up. For the purposes of this
                  study, an investigator may classify a medical condition as a nonsignificant
                  disorder despite the fact that the subject receives treatment. Subjects having
                  controlled Stage 1 hypertension (blood pressure of 140-159 mmHg systolic and/or
                  90-99 mmHg diastolic) are eligible for participation in this study

               -  Normal open angle in a gonioscopic examination

               -  Presence of glaucomatous optic disc changes in biomicroscopy and

               -  Visual field defects in at least two visual field examinations (Reliability
                  criteria: fixation errors &lt; 20%, false positives &lt; 15%, and false negatives &lt;
                  33%) Or

               -  Abnormal circumpapillary retinal nerve fiber layer thinning (RNFL evaluated by
                  OCT)

          2. Control group

               -  Men and women aged over 18 years

               -  Subject is generally healthy with no current significant or a history of a
                  significant neurological, cardiovascular, pulmonary (including asthma), hepatic,
                  metabolic, rheumatic, autoimmune, hematological or renal disorder, as determined
                  by the investigator's clinical judgment through collection of medical history and
                  performance of a physical examination. A significant disorder is defined as a
                  disease or medical condition associated with impaired health status, requiring
                  regular or current medical treatment and/or follow up. For the purposes of this
                  study, an investigator may classify a medical condition as a nonsignificant
                  disorder despite the fact that the subject receives treatment. Subjects having
                  controlled Stage 1 hypertension (blood pressure of 140-159 mmHg systolic and/or
                  90-99 mmHg diastolic) are eligible for participation in this study

               -  Baseline IOP in both eyes below 21 mm Hg

               -  Normal findings in slitlamp and funduscopic examination

        Exclusion Criteria:

          -  a) Study population: patients with normal tension glaucoma

          -  History of ocular or systemic disease causing optic nerve damage

          -  History of IOP greater than 21 mm Hg (corrected by CCT)

          -  Participation in a clinical trial in the 3 weeks preceding the study

          -  Ocular surgery (including intravitreal injection) during the 3 months preceding the
             study

          -  Ametropia &gt; 6 Dpt

          -  Smoking

          -  pre- or perimenopausal women

          -  Relevant ophthalmic diseases/conditions that could interfere with LSFG measurements
             (e.g. optic nerve head drusen, tilted disc, etc.)

          -  Opacities of the cornea (e.g. corneal scars, corneal oedema), the lens (e.g. LOCS-II
             grading &gt; 2, posterior capsule opacification) or the vitreous (e.g. vitreous
             haemorrhage, asteroid hyalosis)

          -  Patients who are not able to cooperate or with insufficient ability to fixate (tremor,
             nystagmus)

          -  Blood donation in the 3 weeks preceding the study

          -  Symptoms of a clinically relevant illness in the 3 weeks before the first study day

          -  Ocular infection or clinically significant inflammation

          -  Pregnancy, planned pregnancy or lactating

             b) Control group

          -  Abnormal RNFL

          -  Visual field defects

          -  Participation in a clinical trial in the 3 weeks preceding the study

          -  Ocular surgery (including intravitreal injection) during the 3 months preceding the
             study

          -  Ametropia &gt; 6 Dpt

          -  Smoking

          -  Relevant ophthalmic diseases/conditions that could interfere with LSFG measurements
             (e.g. optic nerve head drusen, tilted disc, etc.)

          -  Opacities of the cornea (e.g. corneal scars, corneal oedema), the lens (e.g. LOCS-II
             grading &gt; 2, posterior capsule opacification) or the vitreous (e.g. vitreous
             haemorrhage, asteroid hyalosis)

          -  Patients who are not able to cooperate or with insufficient ability to fixate (tremor,
             nystagmus)

          -  Blood donation in the 3 weeks preceding the study

          -  Symptoms of a clinically relevant illness in the 3 weeks before the first study day

          -  Ocular infection or clinically significant inflammation

          -  Pregnancy, planned pregnancy or lactating
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthias Bolz, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Allgemeines Krankenhaus Linz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AKh Linz</name>
      <address>
        <city>Linz</city>
        <state>Ober√∂sterreich</state>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 17, 2019</study_first_submitted>
  <study_first_submitted_qc>April 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2019</study_first_posted>
  <last_update_submitted>April 17, 2019</last_update_submitted>
  <last_update_submitted_qc>April 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Augenabteilung Allgemeines Krankenhaus Linz</investigator_affiliation>
    <investigator_full_name>Matthias Bolz</investigator_full_name>
    <investigator_title>Prof.</investigator_title>
  </responsible_party>
  <keyword>Normal tension glaucoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Low Tension Glaucoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

